👏🏻👍 Great job!! Fantastic work!!! @VUMC_Cancer @VUMCHemOnc @VUMC_MD Vanderbilt School of Medicine Basic Sciences VandyBiomed Vanderbilt Cell and Developmental Biology Vanderbilt Biochemistry #academictwitter #WomenInSTEM Ben Ho Park Dr. jordan berlin

📣Delighted to launch IACH CAR-T News! Once a month, we will provide the hottest and latest developments and publications in #CARTcell #Cellular_therapy clinical-hematology.org/iach-car-t-new… Roni Shouval Mohamad Mohty Arnon Nagler

I see you Reena Jayani-Kosarzycki @VUMC_Cancer @VUMCHemOnc 😍

So proud of you Reena Jayani-Kosarzycki!!

My awesome mentor Ola Oluwole chairing a session on moving CAR-T to the outpatient setting. Looking forward to improving patient quality of life #tandem23 @VUMC_Medicine @VUMC_Cancer

Bipin Savani , always need a mandatory selfie with my survivorship mentor !! Transplantation and Cellular Therapy Journal #Tandem23

Ola Oluwole It's our team's data, Ola. It takes a village for FULLY outpatient CAR/ALLO program @VUMC_Cancer Bipin Savani Adetola Kassim Indus BMT Group

our outstanding fellow Eden Biltibo soon to be exceptional faculty @VUMCHemOnc @VUMC_Cancer @VUMC_Medicine

Our own Vivek ⁦⁦Vivek Patel, MD⁩ presenting important data that CRS is not essential for response in CAR therapy at the TCT conf. Go Vivek!

🎯🎉ASTCT #Tandem23

#NEWS: Today, we announced the primary overall survival (OS) analysis results, a key secondary endpoint, of our Phase 3 study of CAR T-cell therapy for initial treatment of relapsed/refractory large B-cell lymphoma.

Live from #EBMT23. Thank you all for joining. What a great transplant community ⁦The EBMT⁩ ⁦EBMT Nurses⁩ ⁦IACH⁩

#NEWS: Announcing detailed results from the overall survival analysis of the landmark Phase 3 study of #CARTcell therapy compared with historical standard of care as initial treatment for relapsed/refractory large B-cell lymphoma. #ASCO23

Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Socie… pubmed.ncbi.nlm.nih.gov/37951502/

See the latest #CART #CellTherapy live event from PeerView #Tandem24 #MedEd api.lrn.peerview.com/psocial/share/…

Round 1: Haplo vs. Gene Therapy for Sickle Cell 🥊 #APPtrack #tandem2024 ⁦ASTCT⁩

With my good friends David and Veronika discussing my favorite topic, outpatient CAR at TCT!